eGenesis is a clinical-stage biotechnology company developing human-compatible engineered organs to address the severe global organ shortage. The Company’s proprietary genome engineering platform enables extensive, multiplex gene edits to remove key biological barriers, add protective human transgenes, and inactivate endogenous retroviruses. EGEN-2784, a genetically engineered porcine kidney, is the Company’s lead program and is currently being evaluated in a multi-patient Expanded Access study at MGH. eGenesis is headquartered in Cambridge, MA. 

eGenesis, Inc is seeking a highly motivated and experienced Senior Director, Controller to lead the company’s accounting and financial reporting functions during a pivotal period of growth. Reporting to the VP, Finance, this leader will own the integrity of eGenesis’ financial statements, direct the monthly and quarterly close process, lead the annual audit, and ensure the company’s accounting infrastructure scales with its ambitions. This is a high-visibility role that partners closely with senior leadership and the audit committee on complex accounting matters and cross-functional financial operations. This is a full-time role based in Cambridge, MA.

Base pay range for this job is $180,500-$233,500.